Clinical Characteristics of People With Long-term Type 1 Diabetes: a Cohort Study

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement, Biological, Genetic
Study Type: Observational
SUMMARY

Type 1 diabetes (T1D) is characterized by absolute insulin deficiency. Although the discovery and application of exogenous insulin has prolonged the lifespan of T1D patients, the chronic diabetic complications caused by long-term poor glycemic control will still reduce patients' quality of life and the overall life expectancy. According to the studies focused on long-term T1D, part of the patients with long disease duration showed resistance to microvascular complications, and several protective factors have been identified. The prevalence of T1D in China is extremely low compared to that in the western world, and little is known about the characteristics of patients with long-term T1D in China. Therefore, this study is designed to collect variable clinical and laboratory features of patients with long-term T1D, explore the risk and protective factors for the development of microvascular complications, and provide reference for the prediction and prevention of these complications.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Individuals diagnosed with type 1 diabetes(T1D) according to the 1999 World Health Organization report

• Insulin dependence from disease onset

• with T1D duration of ≥10 years

• able to understand the procedures and methods of this study, voluntarily participate in the study, and agree to sign the informed consent form

Locations
Other Locations
China
Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
RECRUITING
Changsha
Contact Information
Primary
Xia Li, MD/PHD
lixia2014@vip.163.com
+86 17373199692
Time Frame
Start Date: 2022-05-01
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 400
Treatments
long-term T1D
Subjects who has the T1D duration ≥10 years, with or without diabetic complications.
Related Therapeutic Areas
Sponsors
Leads: Second Xiangya Hospital of Central South University

This content was sourced from clinicaltrials.gov